US calls for pause on Johnson & Johnson vaccine over blood clot reports

Your video will begin in 10
Skip ad (3)
US federal authorities have urged health officials to hold off on using the Johnson & Johnson vaccine - because six people out of the 6.8 million who received it have developed blood clots, and one died.
The Johnson & Johnson vaccine is administered in a single dose, is cheaper than other vaccines, and can be kept at regular refrigeration temperatures.
The delay is expected to last just days, but what they uncover about this could have a huge impact on the many countries counting on this vaccine to get them past the pandemic.

Al Jazeera’s Patty Culhane reports from Silver Spring in the US state of Maryland.

- Subscribe to our channel:
- Follow us on Twitter:
- Find us on Facebook:
- Check our website:

#COVID19Vaccine #Johnson&Johnson #VaccineBloodClots
News & Politics
Be the first to comment